171 related articles for article (PubMed ID: 18631314)
41. Incremental drug treatment cost in HIV-positive patients in industry-sponsored clinical trials.
Perrín RS; López FJ
Ann Pharmacother; 2008 Nov; 42(11):1586-91. PubMed ID: 18780807
[TBL] [Abstract][Full Text] [Related]
42. Secure antiretroviral therapy delivery in a resource-limited setting: streamlined to minimize drug resistance and expense.
Kitkungvan D; Apisarnthanarak A; Laowansiri P; Mundy LM
HIV Med; 2008 Oct; 9(8):636-41. PubMed ID: 18643857
[TBL] [Abstract][Full Text] [Related]
43. Comparative cost analysis of outpatient and inpatient rehabilitation for musculoskeletal diseases in Germany.
Zeidler J; Mittendorf T; Vahldiek G; Zeidler H; Merkesdal S
Rheumatology (Oxford); 2008 Oct; 47(10):1527-34. PubMed ID: 18682412
[TBL] [Abstract][Full Text] [Related]
44. The cost of home-based terminal care for people with AIDS in South Africa.
Uys L; Hensher M
S Afr Med J; 2002 Aug; 92(8):624-8. PubMed ID: 12244622
[TBL] [Abstract][Full Text] [Related]
45. ART treatment costs and retention in care in Kenya: a cohort study in three rural outpatient clinics.
Larson BA; Bii M; Henly-Thomas S; McCoy K; Sawe F; Shaffer D; Rosen S
J Int AIDS Soc; 2013 Jan; 16(1):18026. PubMed ID: 23305696
[TBL] [Abstract][Full Text] [Related]
46. Different delivery models for antiretroviral therapy in sub-Saharan Africa in the context of 'universal access'.
Harries AD; Makombe SD; Schouten EJ; Ben-Smith A; Jahn A
Trans R Soc Trop Med Hyg; 2008 Apr; 102(4):310-1. PubMed ID: 18316103
[TBL] [Abstract][Full Text] [Related]
47. Establishment of a public antiretroviral treatment clinic for adults in urban Botswana: lessons learned.
Wester CW; Bussmann H; Avalos A; Ndwapi N; Gaolathe T; Cardiello P; Bussmann C; Moffat H; Mazonde P; Marlink RG
Clin Infect Dis; 2005 Apr; 40(7):1041-4. PubMed ID: 15824998
[TBL] [Abstract][Full Text] [Related]
48. Fast-track treatment initiation counselling in South Africa: A cost-outcomes analysis.
Larson BA; Pascoe SJS; Huber A; Long LC; Murphy J; Miot J; Fraser-Hurt N; Fox MP; Rosen S
PLoS One; 2021; 16(3):e0248551. PubMed ID: 33735206
[TBL] [Abstract][Full Text] [Related]
49. Cost of a dedicated ART clinic.
Harling G; Bekker LG; Wood R
S Afr Med J; 2007 Aug; 97(8):593-6. PubMed ID: 17952216
[TBL] [Abstract][Full Text] [Related]
50. Equity and efficiency in HIV-treatment in South Africa: the contribution of mathematical programming to priority setting.
Cleary S; Mooney G; McIntyre D
Health Econ; 2010 Oct; 19(10):1166-80. PubMed ID: 19725025
[TBL] [Abstract][Full Text] [Related]
51. Treatment outcomes and cost-effectiveness of shifting management of stable ART patients to nurses in South Africa: an observational cohort.
Long L; Brennan A; Fox MP; Ndibongo B; Jaffray I; Sanne I; Rosen S
PLoS Med; 2011 Jul; 8(7):e1001055. PubMed ID: 21811402
[TBL] [Abstract][Full Text] [Related]
52. Recurrent lumbar disc herniation after single-level lumbar discectomy: incidence and health care cost analysis.
Ambrossi GL; McGirt MJ; Sciubba DM; Witham TF; Wolinsky JP; Gokaslan ZL; Long DM
Neurosurgery; 2009 Sep; 65(3):574-8; discussion 578. PubMed ID: 19687703
[TBL] [Abstract][Full Text] [Related]
53. Cost-effectiveness analysis of a worksite clinic: is it worth the cost?
Chenoweth DH; Garrett J
AAOHN J; 2006 Feb; 54(2):84-9; quiz 90-1. PubMed ID: 16509183
[TBL] [Abstract][Full Text] [Related]
54. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
Jahnz-Rózyk K; Targowski T; From S
Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
[TBL] [Abstract][Full Text] [Related]
55. [Assessment of factors associated with patients' comprehension of treatment at the start of antiretroviral therapy].
Braga Ceccato Md; Acurcio Fde A; Vallano A; Comini César C; Crosland Guimarães MD
Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):7-13. PubMed ID: 19217997
[TBL] [Abstract][Full Text] [Related]
56. Comparison of HIV-infected patients' characteristics, healthcare resources use and cost between native and migrant patients.
Wasserfallen JB; Hyjazi A; Cavassini M
Int J Public Health; 2009; 54(1):5-10. PubMed ID: 19142582
[TBL] [Abstract][Full Text] [Related]
57. Sustaining treatment costs: who will pay?
Zewdie D; De Cock K; Piot P
AIDS; 2007 Jul; 21 Suppl 4():S1-4. PubMed ID: 17620744
[No Abstract] [Full Text] [Related]
58. [Comparative cost analysis of outpatient and inpatient rehabilitation for cardiac diseases].
Zeidler J; Mittendorf T; Vahldiek G; von der Schulenburg JM
Herz; 2008 Sep; 33(6):440-7. PubMed ID: 19156379
[TBL] [Abstract][Full Text] [Related]
59. Estimates of the direct cost per case and overall burden of trichomoniasis for the employer-sponsored privately insured women population in the United States, 2001 to 2005.
Owusu-Edusei K; Tejani MN; Gift TL; Kent CK; Tao G
Sex Transm Dis; 2009 Jun; 36(6):395-9. PubMed ID: 19556934
[TBL] [Abstract][Full Text] [Related]
60. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
